Top News

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

Latest News

RNA Medicine Finds Its Way Into Muscle

INSIGHTS

13 Apr 2026

Sarepta's siRNA data confirm muscle-targeted RNA delivery is clinically viable for the first time, opening a new front in rare neuromuscular disease

TECHNOLOGY

4 Mar 2026

The Tiny Carriers Powering mRNA’s Next Leap

A next-generation nanoparticle may make repeat mRNA dosing possible, transforming treatments for chronic diseases

INSIGHTS

2 Mar 2026

A Single Jab for Flu and COVID? EU Says Yes

EU advisers back Moderna’s combo flu and COVID vaccine, setting up a pivotal decision that could reshape seasonal immunization

Researcher using microscope to analyze samples in laboratory

INNOVATION

25 Feb 2026

Layered Nanoparticles Boost mRNA Delivery

Core-shell lipid nanoparticles show early gains in mRNA release but raise new design and safety questions

Scientists working in laboratory developing RNA delivery technologies

PARTNERSHIPS

24 Feb 2026

Can Smarter Nanoparticles Unlock RNA’s Next Wave?

The partners aim to improve LNP stability and targeting as demand rises for scalable, next-generation RNA platforms

INVESTMENT

23 Feb 2026

A £1B Shot in the Arm for UK Vaccine Power

A £1B investment anchors UK mRNA production, with capacity for 100M doses and rapid emergency expansion

Labelled mRNA vaccine vial with syringe, capsules and stethoscope on medical form

MARKET TRENDS

19 Feb 2026

mRNA Groups Press Ahead in Cancer Push

Personalised oncology programmes advance as regulators engage and payers scrutinise costs

2 3 4...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.